uniQure: the buy signal holds through confirmation
uniQure stock gains 0.7% as the buy signal clears its confirmation test
Our view last week
The buy signal on uniQure, triggered last week, holds up under the confirmation test: the stock slips 0.5% but stays pressed against the recent highs, already tested twice. The technical picture stays solid — moving averages aligned, ADX rising for thirteen straight weeks — but the weekly MACD is losing steam and money flow is cooling off. Ranking backs the case: 10th out of 167 open Long positions in US stocks, with a signal strength of 86 out of 100.
This week's summary
uniQure's ADX has been climbing for 14 straight weeks, a sign the trend is gaining conviction, but underneath something is cooling off: the weekly MACD is deteriorating and sellers took over on the last bar. Signal strength stays high, at 86 out of 100, and uniQure stock ranks 11th among the 175 open buys in US stocks. The price is hugging its recent highs, with little room before the next resistance.
IQS Phase
55
ordinary
Signal Strength
86
high · wide & volatile
Sizing
FULL
Ranking
#11 / 175
US stocks in progress
Trade P&L %
+0.21%
from signal to date, no stop loss
Rank position
ranks 11th among the 175 Longs already running for US stocks in our ranking, with a signal strength of 86 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -1.98% · monthly +2.96%
QURE belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content